{"transactions":[{"id":2235229,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":126288,"kind":"person","name":"Ammer Richard","position":1,"cik":"0001843671","reported_name":"Ammer Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T17:32:20.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in four equal quarterly installments such that the stock option is fully vested on the first anniversary of the date of grant."}],"balance_after":7500,"derivative":{"exercise_price":0.51,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001824293-22-000056","document":"wf-form4_165488232409421.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000182429322000056/wf-form4_165488232409421.xml","form_type":"4"}},{"id":2707007,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":126288,"kind":"person","name":"Ammer Richard","position":1,"cik":"0001843671","reported_name":"Ammer Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-18T20:08:23.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":10204,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests as to 50% of the underlying shares of common stock on June 30, 2021, then in two equal installments on September 30, 2021 and December 31, 2021, such that the stock option fully vests on December 31, 2021."}],"balance_after":10204,"derivative":{"exercise_price":3.66,"expiration_date":"2031-05-14","underlying":"Common Stock","underlying_shares":10204},"source":{"system":"sec-edgar","filing":"0001104659-21-068838","document":"tm2116776-6_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000110465921068838/tm2116776-6_4.xml","form_type":"4"}},{"id":2707006,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":126288,"kind":"person","name":"Ammer Richard","position":1,"cik":"0001843671","reported_name":"Ammer Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-18T20:08:23.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in 24 equal monthly installments such that the stock option is fully vested on the second annual anniversary of the date of grant."}],"balance_after":15000,"derivative":{"exercise_price":3.66,"expiration_date":"2031-05-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-21-068838","document":"tm2116776-6_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000110465921068838/tm2116776-6_4.xml","form_type":"4"}},{"id":2862066,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":126288,"kind":"person","name":"Ammer Richard","position":1,"cik":"0001843671","reported_name":"Ammer Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-12T23:02:26.000Z","date":"2021-02-12","kind":"other","acquired":true,"shares":47063,"price":6.4,"value":301203.2,"ownership":{"direct":false,"nature":"By SALMON Pharma GmbH"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued immediately prior to the closing of the initial public offering of the issuer's common stock in connection with the conversion of the promissory notes held by the reporting person, as disclosed in the prospectus, dated February 9, 2021,  filed with the U.S. Securities and Exchange Commission on February 11, 2021, which forms a part of the Registration Statements on Form S-1 (File Nos. 333-249636 and 333-252925), originally filed on October 23, 2020, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":47063,"source":{"system":"sec-edgar","filing":"0001104659-21-022190","document":"tm214979-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000110465921022190/tm214979-8_4seq1.xml","form_type":"4"}}]}